glp-1-directed nmda receptor antagonism for obesity treatment The predicted impact of GLP‐1 (GLP‐1R) density on Caveolae with GLP-1 and NMDA

The active receptor targets are the same, but the formulation, source, and regulatory pathway differ

Ease of Use and Onboarding Process Your weight-loss journey starts with the onboarding experience

Over time, when excretion from the kidneys becomes limited, GI excretion of potassium is significantly enhanced, particularly in individuals undergoing dialysis [15], becoming an important potassium homeostatic mechanism that can also lead to high potassium levels if constipation occurs

What were discovering is that GLP-1 receptors are not just present in the brain, gut and pancreas

They may also slightly increase heart rate

For more information, contact us or book an appointment online